Vantis Vascular announced today announced the first commercial use of its CrossFast integrated microcatheter advanced delivery system. Physicians used CrossFast in a series of ten successful complex high-risk coronary interventional procedures (CHiP). Dr. Amir Kaki performed the first case at St. John’s Hospital in Detroit. Initial cases demonstrated 100% procedural success. Vantis reports quick, reliable […]
Vantis Vascular
Vantis Vascular closes $10M Series B
Vantis Vascular announced today that it successfully closed a Series B-1 preferred financing round worth $10 million. San Jose, California-based Vantis’ latest funding brings the company to $30 million raised to date. The company develops the CrossFast microcatheter guide extension system along with the CrossShock intravascular lithotripsy (IVL) system. It designed CrossFast to help physicians […]
Vantis Vascular wins FDA nod for integrated microcatheter guide extension system
Vantis Vascular announced today that it received FDA 510(k) clearance for its CrossFast integrated microcatheter guide extension system. San Jose, California-based Vantis develops the CrossFast system along with the CrossShock intravascular lithotripsy (IVL) system. It designed CrossFast to help physicians perform faster, easier and safer procedures. The guide extension catheter offers additional support and facilitates […]
Vantis Vascular raises $5M for microcatheter, IVL system
Vantis Vascular announced today that it closed a $5 million SAFE (Simple Agreement for Future Equity) financing round. The company can convert the financing upon its future Series C preferred financing round. It brings the total funding for the company to $24 million to date. San Jose, California-based Vantis plans to use the funds to […]
